They could be boosted though by the acquisition in May of the Greek pharmaceutical company Specifar for 400m euros by Watson Pharmaceuticals of California, which has its headquarters in New Jersey.
Acestea ar putea fi crescute de achiziţionarea, în luna mai, a companiei farmaceutice greceşti Specifar de către Watson Pharmaceuticals din California, companie având sediul central în New Jersey, pentru suma de 400 milioane de euro.